Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.12M | 13.64M | 15.70M | 18.97M | 20.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.39M | 27.82M | 33.70M | 43.96M | 50.17M |
| Operating Income | -21.39M | -27.82M | -33.70M | -43.96M | -50.17M |
| Income Before Tax | 169.12M | 42.01M | 13.68M | -305.52M | -485.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 169.12 | 42.01 | 13.68 | -305.52 | -485.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 169.12M | 42.01M | 13.68M | -305.52M | -485.01M |
| EBIT | -21.39M | -27.82M | -33.70M | -43.96M | -50.17M |
| EBITDA | -21.30M | -27.73M | -33.60M | -43.86M | -50.07M |
| EPS Basic | 297.85 | 182.77 | 128.17 | -248.63 | -560.81 |
| Normalized Basic EPS | -8.42 | -41.66 | -40.01 | -64.98 | -70.75 |
| EPS Diluted | 297.28 | 182.21 | 127.89 | -248.63 | -560.81 |
| Normalized Diluted EPS | -8.40 | -41.65 | -40.01 | -64.98 | -70.75 |
| Average Basic Shares Outstanding | 9.61M | 2.68M | 2.64M | 2.93M | 4.32M |
| Average Diluted Shares Outstanding | 9.61M | 2.68M | 2.64M | 2.93M | 4.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |